CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 266 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $24,024,163 | +387.0% | 346,569 | +669.3% | 0.00% | +300.0% |
Q4 2023 | $4,933,426 | -82.6% | 45,050 | -78.4% | 0.00% | -83.3% |
Q2 2023 | $28,372,337 | +21.2% | 208,789 | -7.4% | 0.01% | +20.0% |
Q1 2023 | $23,417,626 | +46.7% | 225,473 | +25.2% | 0.01% | +25.0% |
Q4 2022 | $15,963,975 | +1.5% | 180,099 | -8.2% | 0.00% | 0.0% |
Q3 2022 | $15,725,666 | -9.1% | 196,154 | +8.6% | 0.00% | 0.0% |
Q2 2022 | $17,297,895 | -44.0% | 180,638 | -13.2% | 0.00% | -42.9% |
Q1 2022 | $30,909,690 | +15.8% | 208,076 | +10.5% | 0.01% | +40.0% |
Q4 2021 | $26,698,000 | +11.8% | 188,331 | +3.2% | 0.01% | 0.0% |
Q3 2021 | $23,884,000 | -22.2% | 182,556 | -18.3% | 0.01% | -28.6% |
Q2 2021 | $30,702,000 | -7.1% | 223,403 | -11.7% | 0.01% | -12.5% |
Q1 2021 | $33,039,000 | +8.8% | 252,997 | -6.7% | 0.01% | +14.3% |
Q4 2020 | $30,368,000 | +44.7% | 271,143 | +1.6% | 0.01% | +16.7% |
Q3 2020 | $20,989,000 | -26.2% | 266,797 | -32.4% | 0.01% | -25.0% |
Q2 2020 | $28,429,000 | +12.2% | 394,904 | -10.8% | 0.01% | -11.1% |
Q1 2020 | $25,341,000 | -51.3% | 442,487 | -4.9% | 0.01% | -40.0% |
Q4 2019 | $52,020,000 | +7.4% | 465,174 | -7.7% | 0.02% | 0.0% |
Q3 2019 | $48,447,000 | +12.4% | 503,862 | 0.0% | 0.02% | +15.4% |
Q2 2019 | $43,115,000 | +0.4% | 503,862 | -2.4% | 0.01% | -7.1% |
Q1 2019 | $42,942,000 | +29.6% | 516,261 | 0.0% | 0.01% | +16.7% |
Q4 2018 | $33,144,000 | -19.0% | 516,261 | 0.0% | 0.01% | -7.7% |
Q3 2018 | $40,898,000 | +8.2% | 516,261 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $37,791,000 | +36.1% | 516,261 | +17.8% | 0.01% | +30.0% |
Q1 2018 | $27,762,000 | +47.6% | 438,361 | +18.8% | 0.01% | +42.9% |
Q4 2017 | $18,807,000 | -15.6% | 368,985 | -13.2% | 0.01% | -12.5% |
Q3 2017 | $22,293,000 | +25.5% | 424,871 | +21.8% | 0.01% | +14.3% |
Q2 2017 | $17,763,000 | +51.8% | 348,714 | +32.3% | 0.01% | +40.0% |
Q1 2017 | $11,702,000 | +26.7% | 263,510 | +26.0% | 0.01% | +25.0% |
Q4 2016 | $9,236,000 | +83.9% | 209,101 | +59.4% | 0.00% | +100.0% |
Q3 2016 | $5,021,000 | -64.0% | 131,219 | -55.1% | 0.00% | -71.4% |
Q2 2016 | $13,953,000 | +13.8% | 292,333 | 0.0% | 0.01% | +16.7% |
Q1 2016 | $12,260,000 | -4.8% | 292,333 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $12,877,000 | -7.7% | 292,333 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $13,956,000 | -18.1% | 292,333 | 0.0% | 0.01% | -22.2% |
Q2 2015 | $17,034,000 | +15.4% | 292,333 | 0.0% | 0.01% | +28.6% |
Q1 2015 | $14,760,000 | +12.3% | 292,333 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $13,143,000 | +22.0% | 292,333 | 0.0% | 0.01% | +16.7% |
Q3 2014 | $10,769,000 | -45.4% | 292,333 | -34.6% | 0.01% | +20.0% |
Q2 2014 | $19,730,000 | +103.2% | 446,856 | +100.0% | 0.01% | 0.0% |
Q1 2014 | $9,708,000 | +2.2% | 223,428 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $9,496,000 | +25.0% | 223,428 | 0.0% | 0.01% | +25.0% |
Q3 2013 | $7,594,000 | +22.2% | 223,428 | +12.3% | 0.00% | 0.0% |
Q2 2013 | $6,216,000 | +89.3% | 198,955 | +106.4% | 0.00% | +100.0% |
Q1 2013 | $3,283,000 | +19.5% | 96,373 | 0.0% | 0.00% | 0.0% |
Q3 2012 | $2,747,000 | +3.9% | 96,373 | 0.0% | 0.00% | 0.0% |
Q2 2012 | $2,644,000 | – | 96,373 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |